Related Experiment Video
Updated: Jul 1, 2026
08:19
Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
Published on: April 22, 2019
Keratinocyte-conditioned media regulate collagen expression in dermal fibroblasts
Abdi Ghaffari1, Ruhangiz T Kilani, Aziz Ghahary
1Department of Surgery, BC Professional Firefighter's Burn and Wound Healing Research Lab, University of British Columbia, Vancouver, British Columbia, Canada.
The Journal of Investigative Dermatology
|September 13, 2008
Summary
Keratinocytes release factors that inhibit excessive type I collagen production by fibroblasts, potentially preventing fibrotic scarring during wound healing. These keratinocyte-derived collagen-inhibitory factors (KD-CIFs) offer new therapeutic targets.
Area of Science:
- Dermatology
- Cell Biology
- Biochemistry
Background:
- Excessive extracellular matrix (ECM) production, particularly type I collagen, in dermal wound healing can cause fibrotic conditions like keloids and hypertrophic scarring (HSc).
- Fibroblast collagen production is influenced by epidermal-dermal interactions, suggesting regulatory factors may be involved in scar formation.
Purpose of the Study:
- To identify and characterize keratinocyte-derived collagen-inhibitory factors (KD-CIFs) that regulate fibroblast type I collagen synthesis.
- To investigate the role of epidermal-dermal interactions in controlling fibroblast collagen production.
Main Methods:
- Co-culturing human fibroblasts with keratinocytes and treating fibroblasts with keratinocyte-conditioned medium (KCM).
- Assessing pro-alpha1(I) collagen mRNA and protein expression in fibroblasts.
- Characterizing KD-CIFs based on molecular weight, heat stability, and pH stability.
Main Results:
- Fibroblasts co-cultured with keratinocytes or treated with KCM showed significantly reduced collagen mRNA and protein levels.
- A high-molecular-weight factor (>30 kDa) in KCM demonstrated inhibitory activity.
- The inhibitory factor remained stable at 56°C and pH 2, and its release was not affected by keratinocyte differentiation.
Conclusions:
- Keratinocytes release factors (KD-CIFs) that inhibit type I collagen synthesis in fibroblasts.
- These KD-CIFs, with a molecular weight between 30-50 kDa, play a role in regulating fibroblast collagen production.
- Understanding these factors could lead to novel strategies for managing fibrotic scarring in wound healing.
Related Concept Videos
01:09Introduction to Fibroblasts
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
01:11Fibril-associated Collagen
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...